INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)
$10.21 -0.46 (-4.3112%)
Analysed INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) News Sources
Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?
29-06-2026
yahoo.com
Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57%
01-07-2026
fool.com
Is Intellia Therapeutics, Inc. (NTLA) A Good Stock To Buy Now?
03-07-2026
yahoo.com
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06-07-2026
yahoo.com
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics
08-07-2026
fool.com
Wall Street Doubles Down on Wolfspeed Short Positions Over Cash Burn Fears
08-07-2026
barchart.com
Intellia Therapeutics (NTLA) Stock Looks Rich On Sales But Weak On Returns
09-07-2026
yahoo.com
NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock?
09-07-2026
yahoo.com
Intellia Therapeutics (NTLA) Could Be 37% Undervalued After Phase 3 Lonvo Z Success
09-07-2026
yahoo.com
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
20-07-2026
yahoo.com
What is the current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is $10.21.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is $-0.46.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is -4.3112%.
What is the most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is .
SEC-8K** Filing Available For INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.